Bacterial contamination threatens the safety and health of both hospital and lab patients and staff.  Even though these areas appear sterile, they might not be.

In 2014 the CDC estimated that “approximately 1 in 25 U.S. patients has at least one infection contracted during their hospital care, adding up to about 722,000 infections,” and “About 75,000 patients with healthcare-associated infections died during their hospitalizations.” (1) They report that yearly about 2 million people in the US become infected with bacteria resistant to antibiotics and approximately 23,000 of them die because of it. Lab Manager Magazine stated that in 2010, 8.45 percent of cultures commercially tested from biopharmaceutical sources were contaminated with fungi and bacteria. (2) Their use of antibiotics to prevent bacterial contamination in cultures masks contaminations present, and ups the amount of antibiotic-resistant bacterial strains.
These risks, coupled with The Daily Record’s report that “A new type of medical malpractice lawsuit is on the rise—claims based on hospital infections,” (3) must be addressed.

PREVENTION IS KEY

Reducing Bacterial Contamination Through Microbial Resistant Coating

 

Our microbial resistant additives* reduce harmful bacteria like Salmonella, E. coli, MRSA, Listeria and other bacteria. Laboratory tested, our protective coatings eliminated 99 percent of bacteria—at room temperature—in only two hours. Our additives don’t replace important infection control practices, they’re a safeguard against further risk.

For more information on how we can help you reduce your facilities risk of contamination, send us a message here: s3sufacesolutions.com/contact-us/

*S3 additives are currently undergoing testing to determine efficacy pending EPA registration under FIFRA.

EPA Disclaimer

 

 

Leave a comment